> ## Content Index
> Fetch the complete content index at: https://entrepreneurplus.co.uk/llms.txt
> Use this file to discover other available public pages before exploring further.

# AlveoGene
- URL: https://entrepreneurplus.co.uk/startups/alveogene/
- Published: 2026-10-15T15:59:01.000Z
- Updated: 2026-10-15T15:59:01.000Z
- Description: Developing inhaled gene therapies for rare respiratory diseases such as alpha-1 antitrypsin deficiency.
- Author: Editorial Desk
- Tags: #ep-startup

![AlveoGene logo](https://storage.ghost.io/c/05/a4/05a4a052-18ab-4836-8924-ec8b322c371c/content/images/2026/10/alveogene-logo.svg) 

Developing inhaled gene therapies for rare respiratory diseases such as alpha-1 antitrypsin deficiency.

- Biotech & Life Sciences
- Seed
- Oxford

Sector

Biotech & Life Sciences

Stage

Seed

Based in

Oxford

Founded

2022

Funding raised

Undisclosed

Website

[alveogene.com](https://alveogene.com/?ref=entrepreneurplus.co.uk)

AlveoGene develops inhaled gene therapies for rare respiratory diseases. It holds an exclusive licence to the InGenuiTy lentiviral delivery platform, built over more than a decade by the UK Respiratory Gene Therapy Consortium with around £72 million of grant funding, which is designed to give long-lasting gene expression in the lung and can be re-dosed. Its first candidate, AVG-001, aims to treat alpha-1 antitrypsin deficiency. The company was created by Oxford Science Enterprises, the Harrington Discovery Institute and the University of Edinburgh's Old College Capital together with six consortium scientists from Imperial, Oxford and Edinburgh.

## Team

- **Gerry McLachlan**, Co-founder [LinkedIn](https://www.linkedin.com/in/gerry-mclachlan-689426338/?ref=entrepreneurplus.co.uk)

[LinkedIn](https://www.linkedin.com/company/alveogene/?ref=entrepreneurplus.co.uk)

[← All UK startups](https://entrepreneurplus.co.uk/startups/) · [Is this your company? Request an update](https://entrepreneurplus.co.uk/startups/submit/)